Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ankle implant tracked for Long-Term success in arthritis patients

NCT ID NCT03247023

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 40 times

Summary

This study followed 65 adults with ankle arthritis (from wear-and-tear, injury, or conditions like rheumatoid arthritis) who received the Cadence Total Ankle System implant. Researchers tracked how long the implant lasted without needing removal or revision, checking at 2, 5, and 10 years. The goal was to see if the device is safe and durable for long-term use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRAUMATIC ARTHRITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHRU Tours

    Tours, 37044, France

  • Clinica Nostra Senhora del Remei

    Barcelona, 08024, Spain

  • Foot and Ankle Institute

    Woluwe-St-Lambert, B-1200, Belgium

  • North Cumbria University Hospitals

    Carlisle, CA2 7HY, United Kingdom

  • St. Michael's Hospital

    Toronto, M5C 1R6, Canada

  • Universitair Ziekenhuis Gent

    Ghent, 9000, Belgium

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Integra Cadence Total Ankle System (ankle replacement implant)

What this could lead to

If successful, this could confirm that the Cadence ankle implant is a safe and durable option for people with severe ankle arthritis, potentially improving mobility and reducing pain for years.

What could go wrong

This trial was terminated early and only enrolled 65 people, so results may be limited. As with any joint replacement, risks include implant loosening, infection, or need for revision surgery.

Conditions

The condition(s) this trial relates to.

osteoarthritis rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.